Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study.

Azzam AY, Essibayi MA, Farkas N, Azab MA, Morsy MM, Elamin O, Elswedy A, Al Zomia AS, Alotaibi HA, Alamoud A, Atallah O, Abukhadijah HJ, Dmytriw AA, Baker A, Khatri D, Haranhalli N, Altschul DJ

Open source

DOI
10.1002/edm2.70019
Published
2025 Mar
Container
Endocrinology, diabetes & metabolism
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/edm2.70019,
  title = {Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study.},
  author = {Azzam AY and Essibayi MA and Farkas N and Azab MA and Morsy MM and Elamin O and Elswedy A and Al Zomia AS and Alotaibi HA and Alamoud A and Atallah O and Abukhadijah HJ and Dmytriw AA and Baker A and Khatri D and Haranhalli N and Altschul DJ},
  year = {2025},
  journal = {Endocrinology, diabetes \& metabolism},
  doi = {10.1002/edm2.70019},
  url = {https://doi.org/10.1002/edm2.70019}
}

RIS

TY  - JOUR
TI  - Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study.
AU  - Azzam AY
AU  - Essibayi MA
AU  - Farkas N
AU  - Azab MA
AU  - Morsy MM
AU  - Elamin O
AU  - Elswedy A
AU  - Al Zomia AS
AU  - Alotaibi HA
AU  - Alamoud A
AU  - Atallah O
AU  - Abukhadijah HJ
AU  - Dmytriw AA
AU  - Baker A
AU  - Khatri D
AU  - Haranhalli N
AU  - Altschul DJ
PY  - 2025
JO  - Endocrinology, diabetes & metabolism
DO  - 10.1002/edm2.70019
UR  - https://doi.org/10.1002/edm2.70019
ER  - 

APA

AY, A., MA, E., N, F., MA, A., MM, M., O, E., A, E., AS, A. Z., HA, A., A, A., O, A., HJ, A., AA, D., A, B., D, K., N, H., & DJ, A. (2025). Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study.. Endocrinology, diabetes & metabolism. https://doi.org/10.1002/edm2.70019

Source records